Arch Biopartners, Inc. (ARCH.V)
1.07
-0.09
(-7.76%)
CAD |
TSXV |
Aug 25, 16:00
Arch Biopartners Max Drawdown (5Y) : 91.80% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 91.80% |
| June 30, 2026 | 91.80% |
| May 31, 2026 | 91.80% |
| April 30, 2026 | 91.30% |
| March 31, 2026 | 90.30% |
| February 28, 2026 | 84.40% |
| January 31, 2026 | 82.20% |
| December 31, 2025 | 82.20% |
| November 30, 2025 | 82.20% |
| October 31, 2025 | 82.20% |
| September 30, 2025 | 80.00% |
| August 31, 2025 | 80.00% |
| July 31, 2025 | 80.00% |
| June 30, 2025 | 80.00% |
| May 31, 2025 | 80.00% |
| April 30, 2025 | 80.00% |
| March 31, 2025 | 80.00% |
| February 28, 2025 | 80.00% |
| January 31, 2025 | 80.00% |
| December 31, 2024 | 80.00% |
| November 30, 2024 | 80.00% |
| October 31, 2024 | 80.00% |
| September 30, 2024 | 80.00% |
| August 31, 2024 | 80.00% |
| July 31, 2024 | 80.00% |
| Date | Value |
|---|---|
| June 30, 2024 | 80.00% |
| May 31, 2024 | 80.00% |
| April 30, 2024 | 80.00% |
| March 31, 2024 | 80.00% |
| February 29, 2024 | 80.00% |
| January 31, 2024 | 80.00% |
| December 31, 2023 | 80.00% |
| November 30, 2023 | 80.00% |
| October 31, 2023 | 79.60% |
| September 30, 2023 | 78.20% |
| August 31, 2023 | 68.20% |
| July 31, 2023 | 62.80% |
| June 30, 2023 | 62.80% |
| May 31, 2023 | 62.80% |
| April 30, 2023 | 59.00% |
| March 31, 2023 | 59.00% |
| February 28, 2023 | 57.00% |
| January 31, 2023 | 56.74% |
| December 31, 2022 | 56.74% |
| November 30, 2022 | 56.74% |
| October 31, 2022 | 56.74% |
| September 30, 2022 | 56.74% |
| August 31, 2022 | 56.74% |
| July 31, 2022 | 56.74% |
| June 30, 2022 | 56.74% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Innovotech, Inc. | 81.03% |
| Kane Biotech, Inc. | 86.96% |
| Quest PharmaTech, Inc. | 94.00% |
| BriaCell Therapeutics Corp. | -- |
| Vaxil Bio Ltd. | 99.63% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -31.39 |
| Beta (5Y) | 1.544 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.46% |
| Historical Sharpe Ratio (5Y) | -0.1803 |
| Historical Sortino (5Y) | -0.3999 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 29.55% |